HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX)
CUSIP: 427746102
Q3 2017 13F Holders as of 30 Sep 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 182,615,507
- Total 13F shares
- 63,406,329
- Share change
- -6,139,605
- Total reported value
- $1,024,008,242
- Put/Call ratio
- 14%
- Price per share
- $16.15
- Number of holders
- 101
- Value change
- -$88,424,754
- Number of buys
- 46
- Number of sells
- 41
Quarterly Holders Quick Answers
What is CUSIP 427746102?
CUSIP 427746102 identifies HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 427746102:
Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
4.7%
|
8,643,739
|
$119,716,000 | — | 30 Jun 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
4.6%
|
8,377,589
|
$116,029,000 | — | 30 Jun 2017 | |
| FMR LLC |
13F
|
Company |
4.4%
|
8,049,235
|
$111,482,000 | — | 30 Jun 2017 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.1%
|
5,641,456
|
$78,134,000 | — | 30 Jun 2017 | |
| Broadfin Capital, LLC |
13F
|
Company |
2.4%
|
4,418,359
|
$61,194,000 | — | 30 Jun 2017 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.8%
|
3,344,517
|
$46,322,000 | — | 30 Jun 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.5%
|
2,796,551
|
$38,732,000 | — | 30 Jun 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.5%
|
2,783,569
|
$38,552,000 | — | 30 Jun 2017 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.3%
|
2,309,604
|
$31,988,000 | — | 30 Jun 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
2,096,465
|
$29,036,000 | — | 30 Jun 2017 | |
| Carlson Capital, L.P. |
13F
|
Company |
1.1%
|
2,094,795
|
$29,013,000 | — | 30 Jun 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.95%
|
1,737,309
|
$24,063,000 | — | 30 Jun 2017 | |
| Rubric Capital Management LP |
13F
|
Company |
0.93%
|
1,700,000
|
$23,545,000 | — | 30 Jun 2017 | |
| HIGHLAND CAPITAL MANAGEMENT LP |
13F
|
Company |
0.88%
|
1,612,102
|
$22,327,000 | — | 30 Jun 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.72%
|
1,307,776
|
$18,113,000 | — | 30 Jun 2017 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.67%
|
1,221,403
|
$16,916,000 | — | 30 Jun 2017 | |
| CITIGROUP INC |
13F
|
Company |
0.59%
|
1,072,628
|
$14,855,000 | — | 30 Jun 2017 | |
| Tourbillon Capital Partners, L.P. |
13F
|
Company |
0.47%
|
850,000
|
$11,773,000 | — | 30 Jun 2017 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.38%
|
689,397
|
$9,548,000 | — | 30 Jun 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.36%
|
650,000
|
$9,003,000 | — | 30 Jun 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.35%
|
636,773
|
$8,817,000 | — | 30 Jun 2017 | |
| Invesco Ltd. |
13F
|
Company |
0.32%
|
575,312
|
$7,968,000 | — | 30 Jun 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.31%
|
570,344
|
$7,899,000 | — | 30 Jun 2017 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.31%
|
570,000
|
$7,894,000 | — | 30 Jun 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.3%
|
556,407
|
$7,706,000 | — | 30 Jun 2017 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.3%
|
549,960
|
$7,617,000 | — | 30 Jun 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
418,280
|
$5,793,000 | — | 30 Jun 2017 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.22%
|
396,256
|
$5,488,000 | — | 30 Jun 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.21%
|
386,626
|
$5,354,000 | — | 30 Jun 2017 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.2%
|
367,390
|
$5,088,000 | — | 30 Jun 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
204,857
|
$2,837,000 | — | 30 Jun 2017 | |
| Lombard Odier Asset Management (USA) Corp |
13F
|
Company |
0.1%
|
175,000
|
$2,424,000 | — | 30 Jun 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.09%
|
170,555
|
$2,363,000 | — | 30 Jun 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
168,777
|
$2,338,000 | — | 30 Jun 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.07%
|
121,800
|
$1,687,000 | — | 30 Jun 2017 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.06%
|
117,183
|
$1,624,000 | — | 30 Jun 2017 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.06%
|
109,657
|
$1,521,000 | — | 30 Jun 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
101,073
|
$1,400,000 | — | 30 Jun 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.05%
|
99,717
|
$1,382,000 | — | 30 Jun 2017 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.05%
|
92,361
|
$1,279,000 | — | 30 Jun 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.05%
|
82,932
|
$1,149,000 | — | 30 Jun 2017 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.04%
|
80,870
|
$1,121,000 | — | 30 Jun 2017 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
80,532
|
$1,115,000 | — | 30 Jun 2017 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
78,500
|
$1,087,000 | — | 30 Jun 2017 | |
| Atika Capital Management LLC |
13F
|
Company |
0.04%
|
78,000
|
$1,080,000 | — | 30 Jun 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
76,349
|
$1,058,000 | — | 30 Jun 2017 | |
| BlueCrest Capital Management Ltd |
13F
|
Company |
0.04%
|
68,434
|
$948,000 | — | 30 Jun 2017 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.04%
|
65,800
|
$911,000 | — | 30 Jun 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
59,700
|
$827,000 | — | 30 Jun 2017 | |
| GAM Holding AG |
13F
|
Company |
0.03%
|
59,100
|
$819,000 | — | 30 Jun 2017 |
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q3 2017
As of 30 Sep 2017,
HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,406,329 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, FMR LLC, JANUS HENDERSON GROUP PLC, Broadfin Capital, LLC, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, KINGDON CAPITAL MANAGEMENT, L.L.C., and CARLSON CAPITAL L P.
This page lists
101
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
102
Q3 2017 holders
101
Holder diff
-1
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.